logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
W

Woo Kyun Bae

chonnam national university
H指数:30
被引数:3,309

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Trastuzumab plus nivolumab with gemcitabine and cisplatin as first-line therapy for HER2-positive unresectable biliary tract cancer: a phase 1b/2 trial

曲妥珠单抗联合纳武利尤单抗与吉西他滨和顺铂作为HER2阳性不可切除胆道癌的一线疗法：一项1b/2期临床试验

Nature Medicine
IF50
2026-09-220
OAAI
Choong-kun Lee; Taek Chung; Il Hwan Kim; Hong Jae Chon; Jin Won Kim; Se Jun Park; Woo Kyun Bae; Junghun Kang; Changhoon Yoo; Dong-Hoe Koo; Sora Kang; Minsuk Kwon; Ju Won Kim; Beodeul Kang; Sejung Park; Woochan Hwang; Chang Ho Ahn; Chang Gon Kim; Hye Jin Choi
Long-term Immunogenicity of the 13-valent Pneumococcal Conjugate Vaccine during Adjuvant Chemotherapy in Patients with Gastric and Colorectal Cancer: A 5-Year Follow-up of a Randomized Controlled Trial

十三价肺炎球菌结合疫苗在胃癌和结直肠癌患者辅助化疗期间的长效免疫原性：一项随机对照试验的5年随访

Cancer Research and Treatment
IF3.8
2026-01-010
OAAI
Kim, Hyeon-Jong; Bang, Hyunjin; Shim, Hyun-Jung; Hwang, Jun Eul; Cho, Sang-Hee; Chung, Ik-Joo; Kang, Seung Ji; Kim, Jong Gwang; Beom, Seung-Hoon; Jang, A-Yeung; Song, Joon Young; Bae, Woo Kyun
A Prospective, Single-Cohort, Open, Multi-center, Observational Study of Sublingual Fentanyl for Breakthrough Cancer Pain: Effectiveness, Safety, and Tolerability in Korean Cancer Patients

一项关于舌下芬太尼治疗突破性癌痛的前瞻性、单队列、开放、多中心、观察性研究：韩国癌症患者中的有效性、安全性和耐受性

CANCER RESEARCH AND TREATMENT
IF3.8
2025-10-010
OAAI
Choi, Youn Seon; Koh, Su-Jin; Bae, Woo Kyun; Kim, Se Hyung; Shin, Seong Hoon; Oh, So Yeon; Bae, Sang Byung; Yang, Yaewon; Song, Eun-Kee; Cho, Yoon Young; Lee, Pyung Bok; Oh, Ho-Suk; Lee, Minyoung; Ahn, Jin Seok
A phase II study of tepotinib in patients with advanced solid cancers harboring MET exon 14 skipping mutations or amplification (KCSG AL19-17) (vol 9, 103668, 2024)

一项关于 tepotinib 在携带 MET 外显子 14 跳跃突变或扩增的晚期实体癌患者中的 II 期研究 (KCSG AL19-17) (第 9 卷，103668，2024)

ESMO OPEN
IF8.3
2025-04-010
PRE
Kang, E. J.; Yang, Y.; Lee, S.; Kim, Y. J.; Lim, S. M.; Ahn, M. -j.; Choi, Y. J.; Lee, Y.; Kim, T. M.; Kim, I.; Ahn, H. K.; Jeung, H. -c.; Lee, S. I.; Oh, S. Y.; Bae, W. K.; Ryu, H.; Park, K. H.; Lee, K. H.
Enhanced thrombopoiesis supplies PD-L1 to circulating immune cells via the generation of PD-L1-expressing platelets in patients with lung cancer

增强的血小板生成通过产生表达PD-L1的血小板，为肺癌患者循环免疫细胞提供PD-L1。

JOURNAL FOR IMMUNOTHERAPY OF CANCER
IF10.6
2025-02-260
OA
Lee, Sung-Woo; Jeong, Saei; Kim, Young Ju; Noh, Jeong Eun; Rho, Kyung Na; Kim, Hee-Ok; Cho, Hyun-Ju; Yang, Deok Hwan; Hwang, Eu Chang; Kyun Bae, Woo; Yun, Sook Jung; Yun, Ju Sik; Park, Cheol-Kyu; Cho, Jae-Ho
Enfortumab vedotin plus pembrolizumab (EV plus P) vs chemotherapy (Chemo) in previously untreated locally advanced or metastatic urothelial carcinoma (la/mUC): Pan-Asian subgroup analysis from EV-302/KEYNOTE-A39

恩夫妥木单抗联合帕博利珠单抗（EV联合P）对比化疗（Chemo）在既往未治疗的局部晚期或转移性尿路上皮癌（la/mUC）中的疗效：EV-302/KEYNOTE-A39的泛亚洲亚组分析

ANNALS OF ONCOLOGY
IF65.4
2024-12-010
PRE
Kikuchi, E.; van der Heijden, M. S.; Perez Valderrama, B.; Gupta, S.; Bedke, J.; Shin, S. J.; Li, J-R.; Guo, J.; Danchaivijitr, P.; Kanesvaran, R.; Park, S. H.; Su, W-P.; Kandori, S.; Bae, W. K.; Wong, A. S.; Lu, J.; Yu, X.; Shetty, A.; Bavle, A. A.; Powles, T. B.
Second-line chemoimmunotherapy with nivolumab and paclitaxel in immune-related biomarker-enriched advanced gastric cancer: a multicenter phase Ib/II study

nivolumab和紫杉醇二线化学免疫治疗免疫相关生物标志物富集的晚期胃癌: 一项多中心Ib/II期研究

GASTRIC CANCER
IF5.1
2023-10-315
PRE
Lee, Choong-kun; Lee, Jii Bum; Park, Se Jung; Che, Jingmin; Kwon, Woo Sun; Kim, Hyo Song; Jung, Minkyu; Lee, Seulkee; Park, Sook Ryun; Koo, Dong-Hoe; Lee, Hyun Woo; Bae, Woo Kyun; Jeung, Hei-Cheul; Hwang, In Gyu; Kim, Hyunki; Nam, Chung Mo; Chung, Hyun Cheol; Rha, Sun Young
Pexa-vec (thymidine kinase-deactivated vaccinia virus plus GM-CSF) in combination with cemiplimab (REGN2810; ANTIPD-1) for metastatic or unresectable renal cell carcinoma REN026: Results from a phase II study
ANNALS OF ONCOLOGY
IF65.4
2023-10-011
OAAI
Rha, S. Y.; Bae, W. K.; Kim, C.; Oh, S. Y.; Lee, H. W.; Park, K.; Mar, N.; Kichenadasse, G.; Ha, H. K.; Pachynski, R.; Park, I.; Park, K. H.; Kim, S. H.; Folefac, E.; Mathias, M. D.; Seebach, F.; Ma, S.; Carranza, L.; Beom, S-H.; Merchan, J. R.

研究方向

暂未获取到该数据
S
Sang‐Hee Cho
H 指数:32论文数:232被引数:3,931
J
Jun‐Eul Hwang
H 指数:32论文数:235被引数:4,292
I
Ik‐Joo Chung
H 指数:31论文数:228被引数:4,071
I
Ik Joo Chung
H 指数:22论文数:125被引数:3,090
H
Hyun Jeong Shim
H 指数:15论文数:68被引数:689
M
Myong‐Suk Park
H 指数:10论文数:28被引数:373
S
Sun Young Rha
H 指数:86论文数:1,323被引数:3.4万
L
Lothar Hennighausen
H 指数:102论文数:459被引数:4.1万
I
In‐Kyu Park
H 指数:54论文数:274被引数:9,213
K
Kyung Keun Kim
H 指数:41论文数:278被引数:5,146